Jack Murtha

What’s going on with VR, machine learning for dementia detection and Fitbit?

They saw a 90 percent improvement in patients who had low prediction performance.

Can MinuteClinic Video Visits change healthcare?

Thanks to FHIR, no data passes through Apple servers.

Aidoc received clearance for a technology that flags acute intracranial hemorrhages.

Healthcare organizations reported 31 privacy incidents last month.

Its cloud-based solutions include patient monitoring, telehealth and more.

The partnership is another sign of the wearables company’s evolving business model.

The problems illustrate why the bipartisan push toward interoperability is important.

Administrator Seema, Verma, M.P.H., rallied the crowd at the ONC Interoperability Forum in Washington, D.C.

Data Book explores consent through the story of Henrietta Lacks and talks germline editing with Marcy Darnovsky, Ph.D.

The AI sector is growing at breakneck speed.

What the UnityPoint Health attack means.

23andMe, Ancestry and others agreed to detailed transparency, separate consent for third-party sharing and limits on police disclosure.

The direct-to-consumer genetic testing market goes further in the green.

Sangamo, Verily and IBM all made headlines.

Data and AI are at the heart of the latest partnership for a very busy IBM.

New research suggests digital strategies work without breaking the bank.

The pharma giant hopes to use the data for drug discovery.

What does the Center for Biomedical Blockchain Research aim to accomplish?

The gene-editing company paid $84.2 million for the French business.

The contested civil complaint might shed light on his departure from the genomics heavyweight.

Its cloud-based solutions connect payers and providers.

The week’s most popular health IT news and opinions.

Guest Colin Hung discusses how healthcare can prioritize patient input.

The agency created the role to support the goals of MyHealthEData.

The startup says its sequencing tech is quick, accurate, and inexpensive.

The deal extends the use of AI to fuel precision oncology treatments.

From HHS to the FDA, participants are tackling the problem from several angles.

Leaders today focused on E&M visits when promoting the rule.